Skip to main content
. 2020 May 4;583:119396. doi: 10.1016/j.ijpharm.2020.119396

Table 2.

Binding constants, K1:1 (M−1), for various substrates, progesterone, testosterone, hydrocortisone, digoxin and phenytoin, with β-cyclodextrin (β-CD) and a number of modified β-cyclodextrins (see footnotes for details) from Rajewski (1990).

Binding Constants, K1:1 (M−1)
Progesterone Testosterone Hydrocortisone Digoxin Phenytoin
β-Cyclodextrin NDf 1.78 × 104 4.12 × 103 2.82 × 104 1.51 × 103
6-Mono Sulfonatea 1.99 × 102 6.36 × 101 ND ND ND
6-Heptakis Sulfonateb 2.03 × 102 7.34 × 101 ND ND 3.56 × 101
HP-β-CDc 1.12 × 104 1.16 × 104 1.34 × 103 4.90 × 103 1.07 × 103
SPE1-β-CDd 1.66 × 104 1.87 × 104 3.89 × 103 2.74 × 104 1.03 × 103
SPE3.6-β-CDd 1.19 × 104 1.43 × 104 1.74 × 103 1.41 × 104 1.31 × 103
SPE7-β-CDd 7.68 × 103 9.63 × 103 9.98 × 102 5.29 × 103 8.24 × 102
SBE1-β-CDe 1.72 × 104 1.64 × 104 3.83 × 103 2.76 × 104 1.22 × 103
SBE4.7-β-CDe 1.57 × 104 1.82 × 104 2.69 × 103 1.71 × 103 1.26 × 103
SBE7-β-CDe 1.83 × 104 2.25 × 104 2.15 × 103 6.88 × 103 7.56 × 102
a

Mono-(6-deoxy-sulfonic acid)- β-cyclodextrin, sodium salt.

b

Heptakis-(6-deoxy-sulfonic acid)- β-cyclodextrin, sodium salt.

c

Hydroxypropyl-β-cyclodextrin, MolecusolTM, Pharmatec, Inc.

d

Sulfopropylether-β-cyclodextrins with the degree of substitution indicated by the subscript after the SPE.

e

Sulfobutylether-β-cyclodextrins with the degree of substitution indicated by the subscript after the SBE.

f

Not determined.